The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval ...

Scientists discover that the CD74 protein could predict the effectiveness of immunotherapy, advancing colon cancer treatment.

A group of 18 colorectal cancer patients experienced complete remission after taking the experimental drug dostarlimab for ...

Pfizer PFE announced positive top-line results from the progression-free survival (PFS) analysis of a late-stage study of its ...

Scientists Discover How Excessive Red Meat Consumption Increases Colorectal Cancer Risk Oct ... Cancer Biologists Discover a New Mechanism for an Old Drug Oct. 7, 2024 — Doctors have long ...

With minimal blood loss and scarring, and faster recovery period, robotic surgeries are becoming game changers in the ...

Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...

Doctors in Dallas and other parts of Texas are beginning to use a new blood test that can detect colon cancer earlier. The ...

Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...

A new study has found that a simple blood test can accurately detect colon cancer in middle-aged and older adults. The ...

An accurate new blood test for colon cancer, the fourth leading cause of cancer deaths in the US, has been reported.

A new study has found that taking a small daily dose of aspirin could help stop colon cancer from returning in some patients.